| Funding Opportunity ID: |
319233 |
| Opportunity Number: |
RFA-HD-20-010 |
| Opportunity Title: |
Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Health
Income Security and Social Services |
| Category Explanation: |
|
| CFDA Number(s): |
93.865 |
| Eligible Applicants: |
Small businesses |
| Additional Information on Eligibility: |
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Aug 07, 2019 |
| Close Date: |
Dec 03, 2019 |
| Last Updated Date: |
Aug 07, 2019 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$2,000,000 |
| Expected Number of Awards: |
|
| Description: |
The purpose of this FOA is to encourage small businesses to collaborate with scientists and clinicians in the fields of female and male reproductive health, infertility, andrology, and/or gynecology to adapt discoveries in omics technologies such as genomics, epigenomics and metabolomics, as well as identification of disease biomarkers to the development of new devices, assays, digital apps, or technologies to improve the specificity of diagnosis and clinical care of infertility and to advance the application of precision medicine to reproductive health. |
| Version: |
1 |
|
